Philippe Gabriel Steg, Michel Marre. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Atherosclerosis/etiologyAtherosclerosis/prevention & controlDiabetes Mellitus, Type 2/complicationsDiabetes Mellitus, Type 2/drug therapyHumansHypoglycemic Agents/therapeutic usePioglitazoneSulfonylurea Compounds/therapeutic useThiazolidinediones/therapeutic use
Substances: See more » Hypoglycemic AgentsSulfonylurea CompoundsThiazolidinedionesglimepiridePioglitazone
Year: 2008 PMID: 18378632 DOI: 10.1001/jama.299.13.1603
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272